Tyrocidine A1

General Information


DRACP ID  DRACP03513

Peptide Name   Tyrocidine A1

Sequence  fPFfNQYVKL

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C49H69N11O10

Absent amino acids  ACDEGHIMRSTW

Common amino acids  FKLNPQVY

Mass  113286

Pl  9.3

Basic residues  1

Acidic residues  0

Hydrophobic residues  3

Net charge  1

Boman Index  -593

Hydrophobicity  -30

Aliphatic Index  68

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  165.56

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17462586

Title  Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis

Doi Not available

Year  2007

Literature 2

Pubmed ID 19586775

Title  Anti-listerial activity and structure-activity relationships of the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6090

DRACP is developed by Dr.Zheng's team.